Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report
| Autor: | Pascal Van Eeckhout, Philippe D'Abadie, Thierry Duprez, Fanny Collette, Marc Hamoir, Sandra Schmitz, Jean-Pascal Machiels |
|---|---|
| Přispěvatelé: | UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'oncologie médicale |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Medicine (General)
Anti-Androgen Locally advanced Case Report Case Reports 030204 cardiovascular system & hematology Apocrine adenocarcinoma 03 medical and health sciences R5-920 0302 clinical medicine metastatic cancer anti-androgen therapy androgen receptor Primary cutaneous apocrine adenocarcinoma Medicine Neoplasm sweat glands business.industry General Medicine medicine.disease Androgen receptor 030220 oncology & carcinogenesis Cancer research business anti‐androgen therapy |
| Zdroj: | Clinical Case Reports, Vol. 8, no. 12, p. 3472-3478 (2020) Clinical Case Reports Clinical Case Reports, Vol 8, Iss 12, Pp 3471-3477 (2020) |
| Popis: | Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti‐androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|